2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.
暂无分享,去创建一个
[1] S. Irwin,et al. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse , 1968, Psychopharmacologia.
[2] Maria Novella Romanelli,et al. Design and study of piracetam-like nootropics, controversial members of the problematic class of cognition-enhancing drugs. , 2002, Current pharmaceutical design.
[3] C. Ghelardini,et al. Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity. , 2000, Journal of medicinal chemistry.
[4] T. Nishizaki,et al. Nefiracetam facilitates hippocampal neurotransmission by a mechanism independent of the piracetam and aniracetam action , 2000, Brain Research.
[5] K. Nakamura,et al. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] C. Ghelardini,et al. Design, synthesis, and preliminary pharmacological evaluation of 1, 4-diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents. , 2000, Journal of medicinal chemistry.
[7] M. Raiteri,et al. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices. , 1999, The Journal of pharmacology and experimental therapeutics.
[8] G. Rose,et al. Cognition enhancement strategies by ion channel modulation of neurotransmission. , 1999, Current pharmaceutical design.
[9] T. Narahashi,et al. Modulation of the neuronal nicotinic acetylcholine receptor-channel by the nootropic drug nefiracetam , 1999, Brain Research.
[10] K. Nakamura,et al. Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. , 1998, European journal of pharmacology.
[11] Sung Ju Cho,et al. Investigations of Novel Azomethine Ylide‐Forming Photoreactions of N‐ Silylmethylimides. , 1995 .
[12] J. Lehmann,et al. Effects of putative cognition enhancers on the NMDA receptor by [3H]MK801 binding. , 1995, European journal of pharmacology.
[13] A. Senning,et al. SYNTHETIC AND ANALYTICAL ASPECTS OF THE CHEMISTRY OF PIRACETAM-TYPE SUBSTITUTED PYRROLIDINES. A REVIEW , 1995 .
[14] Sung Ju Cho,et al. Investigations of Novel Azomethine Ylide-Forming Photoreactions of N-Silylmethylimides , 1995 .
[15] B. Testa,et al. X-ray crystal structure, partitioning behavior, and molecular modeling study of piracetam-type nootropics: insights into the pharmacophore. , 1995, Journal of medicinal chemistry.
[16] A. Senning,et al. Piracetam and other structurally related nootropics , 1994, Brain Research Reviews.
[17] F. Mauguière,et al. Long‐term and high‐dose piracetam treatment of Alzheimer's disease , 1993, Neurology.
[18] R. Mazurkiewicz. An Efficient Synthesis of N,N-Disubstituted 5-Aminooxazoles , 1992 .
[19] G. Pepeu,et al. Nootropic drugs and brain cholinergic mechanisms , 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[20] W. Fröstl,et al. The Families of Cognition Enhancers , 1989, Pharmacopsychiatry.
[21] C. Mondadori,et al. The Effects of Nootropics on Memory: New Aspects for Basic Research , 1989, Pharmacopsychiatry.
[22] W. Herrmann,et al. Psychostimulants, analeptics, nootropics: an attempt to differentiate and assess drugs designed for the treatment of impaired brain functions. , 1988, Pharmacopsychiatry.
[23] C. Perrin,et al. Absence of stereoelectronic control in hydrolysis of cyclic amidines. , 1986, Journal of the American Chemical Society.
[24] E. Pinto,et al. [Psychostimulants]. , 1968, Revue medicale de Liege.
[25] M. Jarvik,et al. An Improved One-Trial Passive Avoidance Learning Situation , 1967, Psychological reports.
[26] C. Giurgea,et al. A GABA-related hypothesis on the mechanism of action of the antimotion sickness drugs. , 1967, Archives internationales de pharmacodynamie et de therapie.
[27] C. Niemann,et al. The Interaction of α-Chymotrypsin with a Series of α-N-Acetyl-α-amino Acid Methylamides1 , 1959 .
[28] D. McLachlan. X-ray crystal structure , 1957 .
[29] O. Brady,et al. CCCXX.—The isomerism of the oximes. Part XXVIII. The Beckmann rearrangement of the N-methyl ethers of aldoximes , 1926 .